[Anesthesia in coronary disease].
Patients undergoing non-cardiac surgery and who have coronary artery disease run a high risk of myocardial infarct. Diagnosis and postoperative management is presently based on assessment of cardiac troponin I. Associated with optimal postoperatory management, several approaches can limit the occurrence of postoperatory coronary complications and improve the life expectancy of surgical patients with high cardiovascular risk. They include the possibility of preoperatory myocardial revascularisation and the prophylactic, postoperatory administration of cardiovascular medications (non-steroidal anti-inflammatory drugs, beta-blockers and alpha 2 receptor agonists).
Coriat
P
P
Département d'anesthésie réanimation Groupe hospitalier La Pitié-La Salpêtrière 75013 Paris. pierre.coriat@psl.ap-hop-paris.fr
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000768:Anesthesia, General / Q000009:adverse effects*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D003327:Coronary Disease / Q000150:complications*; D006801:Humans; D008017:Life Expectancy; D009203:Myocardial Infarction / Q000209:etiology* / Q000517:prevention & control; D009204:Myocardial Revascularization; D011183:Postoperative Complications / Q000517:prevention & control*; D013514:Surgical Procedures, Operative / Q000009:adverse effects
D000319:Adrenergic beta-Antagonists; D000894:Anti-Inflammatory Agents, Non-Steroidal